share_log

华东医药:国盛证券有限责任公司关于华东医药股份有限公司2022年限制性股票激励计划调整回购价格及回购注销部分限制性股票事项之独立财务顾问报告

Huadong Medicine: Independent Financial Advisory Report of Guosheng Securities Co., Ltd. on the 2022 Restricted Stock Incentive Plan of Huadong Pharmaceutical Co., Ltd. on the adjustment of repurchase prices and the repurchase and cancellation of some restricted stocks

SZSI ·  May 30, 2024 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more